Kendall David M 4
4 · MANNKIND CORP · Filed Feb 3, 2020
Insider Transaction Report
Form 4
MANNKIND CORPMNKD
Kendall David M
Chief Medical Officer
Transactions
- Purchase
Common Stock, $0.01 Par Value
2020-01-31$0.95/sh+2,304$2,189→ 52,154 total
Footnotes (1)
- [F1]The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2020.